The Leukemia & Lymphoma Society of Canada
Florence Wong is an accomplished finance professional with extensive experience in various leadership roles in finance and accounting. Currently serving as the Director of Finance and Risk at The Leukemia & Lymphoma Society of Canada since June 2023, Florence previously held the position of Senior Accounting Manager at Concord Pacific Developments Inc. and Controller at ServiceMaster Restore of Vancouver, where significant contributions were made to streamline financial operations and reporting. Florence's background also includes managerial roles at Fraser Health Authority and KPMG, where a strong emphasis was placed on financial report production and tax compliance for client organizations. Early career experience includes work as a Senior Accountant at Berris Mangan, Chartered Accountants, and as a Barista at Starbucks, demonstrating a commitment to quality customer service and relationship building. Florence holds a Bachelor of Business Administration with a focus on Accounting and Human Resources from Simon Fraser University.
This person is not in the org chart
This person is not in any teams
The Leukemia & Lymphoma Society of Canada
The Leukemia & Lymphoma Society of Canada (LLSC) is a voluntary health agency dedicated to blood cancer. LLSC funds lifesaving blood cancer research across Canada and worldwide, and provides free information and support services. We won’t stop until there is a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms and are able to improve the quality of life of people affected by blood cancers and their families by funding life-enhancing research and providing educational resources, services and support. Our strategy to achieve the mission is based on three areas of focus: research, patient support and advocacy. In 2017, we invested almost $7.4 million in the creation of programs and delivery of services to improve the lives of Canadians affected by blood cancers from coast to coast. This investment included a commitment of over $4.1 million in innovative, life-changing research to accelerate new cancer treatments, therapies, and cures; and $3.3 million towards funding patient services, programs and education across Canada. Everything we do is made possible through the generosity of individuals, corporate partners, and foundations. In the last two decades alone, the Leukemia & Lymphoma Society of Canada has raised $207 million for research and services. We receive no government support.